residual mutant p53 activity linked to cancer survival in males
Published 5 years ago • 836 plays • Length 6:14Download video MP4
Download video MP3
Similar videos
-
1:13
the impact of p53 mutation on survival in egfr-mutated nsclc patients
-
3:23
timing cancer treatment
-
2:36
current knowledge of the tp53 mutation and its role in cll
-
1:06
is there hope for treating tp53-mutated mds?
-
46:06
curing cancer -- overcoming problems on the line
-
2:13
dr. rule on patients with p53-mutated mcl
-
58:31
stanford cancer institute breakthroughs in cancer: luis diaz, md
-
50:49
mrd monitoring in acute myeloid leukemia
-
44:36
e02.1 from li-fraumeni syndrome to tp53-related inherited cancers
-
2:08
identifying tp53 disruptions: a diagnostic measure in cll
-
23:22
chemotherapy resistance: the fault in our cells
-
18:29
aml treatment challenges who, when, and how
-
47:05
current management of primary brain tumors
-
49:19
building a personalized approach to treating men with advanced prostate cancer - evan warner
-
19:12
an approach to diagnosis and staging of mds: from morphology to genetics
-
1:59
key objectives in kidney cancer: treatment sequencing & refining clinical endpoints
-
58:41
frontiers in oncology: judy garber, md, mph
-
30:43
survivorship series: follow up after cancer treatment
-
58:41
update on diagnosis and therapy of plasma cell dyscrasias